Date published: 2026-10-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

uPAR 抗体 (D-5): sc-376118

5.0(1)
寫評論提問
说明书
  • uPAR抗体(D-5)是小鼠单克隆IgG1 κ, 在1篇文献中引用,规格为200 µg/ml
  • 免疫human物种的代表全长uPAR的氨基酸1-290
  • 推荐用于 human 来源的uPAR WB, IP, IF 和 ELISA检测
  • 看 uPAR (E-3): sc-376494,可查看有标记的 uPAR 抗体,包括AC, HRP, FITC, PE, Alexa Fluor® 488, 594, 647, 680 和 790
  • m-IgG Fc BP-HRP和 m-IgG1 BP-HRP是uPAR Antibody (D-5) for WB applications. 的首选辅助检测试剂,这些试剂现与uPAR Antibody (D-5) 打包提供(请参阅下面的订购信息)。
Gene Editing Promo Banner

快捷链接

関連項目

尿激酶纤溶酶原激活剂受体(uPAR),也称为CD87,是一种针对尿激酶纤溶酶原激活剂(uPA)的糖蛋白I锚定表面受体。与uPAR结合后,uPA将表面结合的大血清b-球蛋白、纤溶酶原转化为纤溶酶。纤溶酶,也被称为纤维蛋白溶酶,是一种类胰蛋白酶,作用于Arg-Lys键,诱导纤维蛋白和纤维蛋白原的细胞周围蛋白水解,从而有助于系统激活凝血级联反应。在病变再上皮化、伤口愈合和组织重塑过程中观察到这一途径。已知uPA和uPAR在间充质和上皮来源的肿瘤细胞中过度表达,并且是肿瘤侵袭和转移所必需的。Ras、MEK、ERK和MLCK作为uPAR依赖性信号级联的下游效应物,由uPA结合引发,并以整合素选择性的方式促进细胞迁移。

仅限研究使用。不适用于诊断和治疗用途。

Alexa Fluor® 是Molecular Probes Inc., OR., USA的商标

LI-COR®和 Odyssey® 是LI-COR Biosciences的注册商标

uPAR 抗体 (D-5) 参考文献:

  1. 前列腺癌中的uPA/uPAR靶向。  |  Li, Y. and Cozzi, PJ. 2007. Cancer Treat Rev. 33: 521-7. PMID: 17658220
  2. 使用基于小分子的探针进行UPAR靶向癌症分子成像。  |  Ding, F., et al. 2017. Bioorg Med Chem. 25: 5179-5184. PMID: 28869084
  3. 将GPI锚定的Ly6蛋白uPAR和CD59与病毒感染联系起来。  |  Yu, J., et al. 2019. Viruses. 11: PMID: 31739586
  4. 尿激酶型纤溶酶原激活物受体(uPAR)作为癌症的治疗靶点。  |  Zhai, BT., et al. 2022. J Transl Med. 20: 135. PMID: 35303878
  5. 星形胶质细胞伤口愈合中的uPA/uPAR系统。  |  Yepes, M. 2022. Neural Regen Res. 17: 2404-2406. PMID: 35535878
  6. uPA/uPAR系统在纤维化过程中协调炎症反应、血管稳态和免疫系统。  |  Kanno, Y. 2023. Int J Mol Sci. 24: PMID: 36675310
  7. 用循环AE105变体对体内uPAR表达进行靶向成像。  |  Leth, JM., et al. 2023. Sci Rep. 13: 17248. PMID: 37821532
  8. 人类抗体VH结构域靶向uPAR作为癌症候选治疗药物。  |  Chu, X., et al. 2023. Front Oncol. 13: 1194972. PMID: 37876962
  9. 一种工程化超高亲和力双配体uPAR靶向剂可增强肿瘤靶向性。  |  Cherf, GM., et al. 2024. Biotechnol Bioeng. 121: 3169-3180. PMID: 38965775
  10. uPAR免疫PET在胰腺癌、衰老和化疗诱导的衰老中的作用。  |  Pratt, EC., et al. 2024. J Nucl Med. 65: 1718-1723. PMID: 39362768

订购信息

产品名称产品编号规格价格数量收藏夹

uPAR 抗体 (D-5)

sc-376118
200 µg/ml
CNY2422.00

uPAR (D-5): m-IgG Fc BP-HRP 套装

sc-540515
200 µg Ab; 10 µg BP
CNY2715.00

uPAR (D-5): m-IgG1 BP-HRP 套装

sc-542174
200 µg Ab; 20 µg BP
CNY2715.00

What is the recommended starting dilution for Western blot for sc-376118: uPAR (D-5) monoclonal antibody?

Asked by: Professor Griffin
The recommended starting dilution for Western blot is 1:100 with a dilution range of 1:100-1:1000. This information, along with other technical specifications, is available in the recommended protocol: https://www.scbt.com/scbt/resources/protocols/western-immuno-blotting
Answered by: Technical Support
Date published: 2017-03-22
  • y_2026, m_10, d_24, h_5CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.48
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_zh_CN, sid_376118, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 105ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by FL from Produced positive Western blot data of uPARProduced positive Western blot data of uPAR expression in non-transfected and human uPAR transfected 293T whole cell lysates. -SCBT QC
Date published: 2014-04-08
  • y_2026, m_10, d_23, h_6
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.48
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_zh_CN, sid_376118, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 6ms
  • REVIEWS, PRODUCT
uPAR 抗体 (D-5) is rated 5.0 out of 5 by 1.
  • y_2026, m_10, d_23, h_6
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.48
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_zh_CN, sid_376118, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 89ms
  • REVIEWS, PRODUCT